Johnson & Johnson
JNJ · NYSE
9/28/2025 | 6/29/2025 | 3/30/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $441,082,332 | $369,517,525 | $398,948,850 | $348,089,060 |
| - Cash | $18,231,000 | $18,577,000 | $38,474,000 | $24,105,000 |
| + Debt | $6,387,000 | $50,761,000 | $52,252,000 | $36,634,000 |
| Enterprise Value | $429,238,332 | $401,701,525 | $412,726,850 | $360,618,060 |
| Revenue | $23,993,000 | $23,743,000 | $21,893,000 | $22,520,000 |
| % Growth | 1.1% | 8.5% | -2.8% | – |
| Gross Profit | $16,690,000 | $16,115,000 | $14,536,000 | $15,392,000 |
| % Margin | 69.6% | 67.9% | 66.4% | 68.3% |
| EBITDA | $9,288,000 | $8,742,000 | $15,607,000 | $5,920,000 |
| % Margin | 38.7% | 36.8% | 71.3% | 26.3% |
| Net Income | $5,152,000 | $5,537,000 | $10,999,000 | $3,431,000 |
| % Margin | 21.5% | 23.3% | 50.2% | 15.2% |
| EPS Diluted | 2.12 | 2.29 | 4.54 | 1.41 |
| % Growth | -7.4% | -49.6% | 222% | – |
| Operating Cash Flow | $9,169,000 | $3,878,000 | $4,174,000 | $6,983,000 |
| Capital Expenditures | -$788,000 | -$1,398,000 | -$809,000 | -$2,145,000 |
| Free Cash Flow | $8,381,000 | $2,480,000 | $3,365,000 | $4,838,000 |